VTYX- Ventyx Biosciences, Inc.

Name: Ventyx Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ventyx Biosciences, Inc. (VTYX) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. VTYX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Mohan Raju	2.37M	$18.32M	-
Other	Nuss John	489.5K	$3.78M	-
Other	Forman Mark S	6.0K	$6.2K	-
VP	Gonzales Roy	5.3K	$5.5K	-
Dir	White William Richard	0	-	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 5, 2022	Nuss John79	Chief Scientific Officer	Sell	50,000	$28.23	$1,411,311.41	-8.8%	+56.1%	-92.5%
Dec 5, 2022	Mohan Raju83	Chief Executive Officer	Sell	300,000	$28.97	$8,691,086.69	-6.1%	+56.1%	-92.5%
Dec 2, 2022	Krueger Christopher W82	Chief Business Officer	Sell	50,000	$29.01	$1,450,730.00	-14.2%	+58.7%	-92.4%
Dec 2, 2022	Auster Martin85	Chief Financial Officer	Sale+OE	97,647	$29.01	$2,832,602.76	-67.2%	+58.7%	-92.4%
Dec 1, 2022	Nsv Partners III LP89	10% Owner	Sell	272,545	$29.01	$7,906,881.72	-0.8%	+50.2%	-92.6%
Dec 1, 2022	Subramaniam Somu89	Director, 10% Owner	Sell	272,545	$29.01	$7,906,881.72	-0.8%	+50.2%	-92.6%
Nov 7, 2022	Nsv Partners III LP89	10% Owner	Sell	3,935	$29.08	$114,427.44	-	+68.8%	-89.5%
Nov 7, 2022	Subramaniam Somu89	Director, 10% Owner	Sell	3,935	$29.08	$114,427.44	-	+68.8%	-89.5%
Apr 3, 2022	Krueger Christopher W82	Chief Business Officer	Sale+OE	15,000	$32.88	$493,165.50	-5.2%	-3.7%	+149.2%
Oct 25, 2021	Cormorant Asset Management, LP49	Former 10% Owner	Buy	625,000	$16.00	$10,000,000.00	+79.6%	-21.0%	+50.6%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC